OEC Orion S.A.
Miscellaneous Chemical Products · NYSE · SEC CIK 1609804 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY0.9%
TTM net income YoY-1.6%
TTM EPS YoY0.0%
Revenue 3-yr CAGR-0.8%
Net income 3-yr CAGR—
Margins
Gross margin18.5%
Operating margin4.0%
Net margin-1.8%
FCF margin2.4%
EBITDA margin11.6%
Returns
ROE-8.1%
ROA-1.6%
ROIC (approx.)2.7%
Asset turnover0.94x
Leverage & solvency
Liabilities / assets79.7%
Debt / equity2.48x
Current ratio1.06x
Interest coverage—
Cash quality & payout
Operating cash flow / net income-5.13x
Accruals ratio-10.1%
Payout ratio—
Capex / revenue6.6%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $472.80M | $500.90M | $459.50M | $411.70M | $450.90M | $466.40M | $477.70M | $434.20M |
| Cost of revenue | $382.00M | $407.90M | $380.30M | $334.00M | $365.30M | $368.00M | $379.60M | $344.90M |
| Gross profit | $90.80M | $93.00M | $79.20M | $77.70M | $85.60M | $98.40M | $98.10M | $89.30M |
| R&D expense | $4.90M | $7.20M | $7.30M | $7.50M | $6.90M | $6.50M | $6.60M | $7.00M |
| SG&A expense | $59.90M | $62.70M | $59.10M | $57.10M | $57.50M | $57.70M | $58.40M | $58.10M |
| Operating income | $22.80M | $21.30M | $11.40M | $17.90M | -$53.70M | $32.10M | $31.20M | $23.60M |
| Pretax income | $5.00M | $5.00M | -$3.30M | $3.30M | -$68.10M | $13.00M | $17.50M | $15.60M |
| Income tax | $8.20M | $3.40M | $6.70M | $22.80M | -$500,000 | $4.60M | $8.90M | -$2.10M |
| Net income | -$3.10M | $1.80M | -$9.90M | -$21.10M | -$67.10M | $9.00M | $9.10M | $17.20M |
| EBITDA | $62.40M | $54.20M | $44.10M | $52.60M | -$20.00M | $64.10M | $62.70M | $58.90M |
| EPS (basic) | -0.05 | 0.03 | -0.18 | — | -1.20 | 0.16 | 0.16 | — |
| EPS (diluted) | -0.05 | 0.03 | -0.18 | — | -1.20 | 0.16 | 0.16 | — |
| Dividends declared per share | 0.02 | 0.04 | 0.02 | 0.00 | 0.02 | 0.04 | 0.02 | 0.00 |
| Weighted avg. shares (diluted) | 56.39M | 57.27M | 56.38M | — | 56.25M | 56.32M | 57.20M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $71.30M | $50.80M | $50.50M | $60.70M | $51.30M | $42.60M | $37.50M | $44.70M |
| Receivables | $272.00M | $300.40M | $270.50M | $213.60M | $265.10M | $270.00M | $274.00M | $211.90M |
| Inventory | $280.90M | $275.50M | $251.00M | $277.30M | $278.90M | $285.70M | $297.00M | $290.40M |
| Current assets | $722.40M | $733.60M | $661.50M | $643.80M | $683.50M | $682.50M | $688.60M | $613.30M |
| PP&E, net | $1.04B | $1.05B | $1.06B | $1.07B | $1.05B | $1.03B | $982.40M | $965.00M |
| Goodwill | — | — | — | $0 | $0 | $80.70M | $74.50M | $71.50M |
| Intangibles | $9.50M | $9.90M | $11.90M | $14.20M | $15.80M | $17.20M | $17.50M | $18.50M |
| Total assets | $1.96B | $1.99B | $1.93B | $1.91B | $1.96B | $2.02B | $1.97B | $1.86B |
| Current liabilities | $679.00M | $715.60M | $659.70M | $626.40M | $635.30M | $620.80M | $601.90M | $516.70M |
| Short-term debt | $336.00M | $356.80M | $351.20M | $305.00M | $329.60M | $342.00M | $313.00M | $258.80M |
| Long-term debt | $651.70M | $652.90M | $662.50M | $674.50M | $680.60M | $680.20M | $659.50M | $647.00M |
| Total debt | $987.70M | $1.01B | $1.01B | $979.50M | $1.01B | $1.02B | $972.50M | $905.80M |
| Total liabilities | $1.56B | $1.61B | $1.55B | $1.52B | $1.56B | $1.56B | $1.50B | $1.38B |
| Shareholders' equity | $398.10M | $380.30M | $379.50M | $384.60M | $401.80M | $466.50M | $466.10M | $474.90M |
| Net debt | $916.40M | $958.90M | $963.20M | $918.80M | $958.90M | $979.60M | $935.00M | $861.10M |
| Shares outstanding | 56.52M | 56.52M | 56.39M | 56.15M | 56.15M | 56.05M | 56.46M | 57.24M |
| Cash flow statement | ||||||||
| Operating cash flow | $57.80M | $27.30M | -$12.40M | $92.90M | $68.80M | $53.70M | $400,000 | $94.50M |
| Capital expenditure | $11.80M | $25.40M | $36.10M | $48.70M | $40.90M | $42.20M | $29.20M | $71.00M |
| Free cash flow | $46.00M | $1.90M | -$48.50M | $44.20M | $27.90M | $11.50M | -$28.80M | $23.50M |
| Investing cash flow | -$11.80M | -$25.40M | -$36.10M | -$48.70M | -$40.90M | -$42.20M | -$29.20M | -$71.00M |
| Financing cash flow | -$26.30M | -$2.20M | $39.60M | -$35.70M | -$19.50M | -$7.80M | $21.80M | -$30.00M |
| Depreciation & amortization | $39.60M | $32.90M | $32.70M | $34.70M | $33.70M | $32.00M | $31.50M | $35.30M |
| Stock-based compensation | $3.10M | $3.00M | $1.40M | $3.60M | $3.70M | $3.60M | $2.70M | $4.00M |
| Dividends paid | $1.20M | $1.10M | $1.20M | $1.20M | $1.10M | $1.20M | $1.20M | $1.20M |
| Share buybacks | $0 | $0 | $800,000 | $0 | $0 | $5.00M | $19.80M | $8.70M |
Free plan shows the latest 8 periods; Pro shows all 38 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.